Identification of undeclared active pharmaceutical ingredients in counterfeit herbal medicines used as opioid substitution therapy

References

• Deconinck E, Sacre PY, Courselle P, De Beer JO. Chromatography in the detection and characterization of illegal pharmaceutical preparations. J Chromatogr Sci. 2013;51(8):791–806.10.1093/chromsci/bmt006
   PubMed Web of Science ®Google Scholar
• Hosseini SA, Darbooy Sh, Tehrani Banihashemi SA, Naseri SM, Dinarvand R. Counterfeit medicines: report of a cross-sectional retrospective study in Iran. Public Health. 2011;125(3):165–171.10.1016/j.puhe.2010.11.015
   PubMed Web of Science ®Google Scholar
• Cheraghali, M. Herbal medicine in the Islamic Republic of Iran. Proceeding of the tenth international conference of drug regulatory authorities (ICDRA); 2002 June 24–27; Hong Kong, China.
   Google Scholar
• Mackey TK, Liang BA, York P, Kubic T. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment. Am J Trop Med Hyg. 2015;92(6 Suppl):59–67.10.4269/ajtmh.14-0389
   PubMed Web of Science ®Google Scholar
• General information on counterfeit medicines [Internet]. [cited 2014 Nov 1] Available from: http://www.who.int/medicines/services/counterfeit/overview/en/.
   Google Scholar
• Bale H. 2005. Pharmaceutical counterfeiting: issues, trends, measurement, WIPO/OECD workshop. Available from: http://www.oecd.org/industry/industryandglobalisation/35650404.pdf
   Google Scholar
• Höllein L, Kaale E, Mwalwisi YH, Schulze MH, Holzgrabe U. Routine quality control of medicines in developing countries: analytical challenges, regulatory infrastructures and the prevalence of counterfeit medicines in Tanzania. TrAC Trends Anal Chem. 2016;76:60–70.10.1016/j.trac.2015.11.009
   Web of Science ®Google Scholar
• Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol. 1997;37(4):344–350.10.1002/jcph.1997.37.issue-4
   PubMed Web of Science ®Google Scholar
• Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplements. Iran Red Crescent Med J. 2014;16(3):e15344.
   PubMed Web of Science ®Google Scholar
• Sedaghat M, Mirsadoo T, Ghorbanloo G, Sedaghat SM. Addiction and crimes in Iran. IAU Int J Soc Sci. 2014;4(1):19–26.
   Google Scholar
• Koob, GF, Arends, MA, Le Moal, M. Drugs, Addiction, and the Brain. University of Bordeaux and Neurocentre Magendie Inserm U862, Bordeaux, France, Academic Press; 2014. What is Addiction?; p. 1-27.
   Google Scholar
• Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, Turner KM, Looker KJ, Christensen H, McLean S, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63(8):1094–1104.10.1093/cid/ciw416
   PubMed Web of Science ®Google Scholar
• Parvaresh N, Masoudi A, Majidi-Tabrizi S, Mazhari S. The correlation between methadone dosage and comorbid psychiatric disorders in patients on methadone maintenance treatment. Addict Health. 2012;4(1–2):1–8.
   PubMedGoogle Scholar
• Oyebode O, Kandala NB, Chilton PJ, Lilford RJ. Use of traditional medicine in middle-income countries: a WHO-SAGE study. Health Policy Plan. 2016;31(8):984–991.10.1093/heapol/czw022
   PubMed Web of Science ®Google Scholar
• Khosh kholgh, R, Ghaemi, SZ, Forouhari, S, Roshandel, A. Non-pharmacological Treatment of Addiction. Int Res J Appl Basic Sci. 2013; 4 (6):1370-1378.
   Google Scholar
• Hearn, WL, Walls, HC. Common methods in postmortem toxicology. In: Postmortem toxicology of abused drugs. Karch SB, editor. USA: CRC Press; 2007. Chapter 3; p. 31-66.
   Google Scholar
• US Food and Drug Administration. Dietary supplement labeling guide: Chapter I. General dietary supplement labeling. April 2005. Available from: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/DietarySupplements/ucm070519.htm
   Google Scholar
• Zhang J, Wider B, Shang H, Li X, Ernst E. Quality of herbal medicines: challenges and solutions. Complement Ther Med. 2012;20(1-2):100–106.10.1016/j.ctim.2011.09.004
   PubMed Web of Science ®Google Scholar
• WHO. WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants [Internet]; 2003 [cited 2015 Jan 30]. Available from: http://whqlibdoc.who.int/publications/2003/9241546271.pdf.
   Google Scholar
• World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence [cited 2015 Feb 2]. Available from: www.who.int.
   Google Scholar
• Piralishvili G, Otiashvili D, Sikharulidze Z, Kamkamidze G, Poole S, Woody GE. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the republic of Georgia. J Subst Abuse Treat. 2015;50:32–37.10.1016/j.jsat.2014.10.003
   PubMed Web of Science ®Google Scholar
• Brown, AC. An overview of Herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem Toxicol. In Press Nov 3. pii: S0278-6915 (16)30402-1. doi: 10.1016/j.fct.2016.11.001.
   Web of Science ®Google Scholar
• Dupouy J, Dassieu L, Bourrel R, Poutrain JC, Bismuth S, Oustric S, Lapeyre-Mestre M. Effectiveness of drug tests in outpatients starting opioid substitution therapy. J Subst Abuse Treat. 2013;44(5):515–521.10.1016/j.jsat.2012.11.006
   PubMed Web of Science ®Google Scholar
• Mastropietro DJ, Omidian H. Abuse-deterrent formulations: Part 2: commercial products and proprietary technologies. Expert Opin Pharmacother. 2015;16(3):305–323.
   PubMed Web of Science ®Google Scholar
• Aronson, JK, editor. Meyler’s side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. Sixteenth Edition. Elsevier; 2015; p. 1009.
   Google Scholar
• UN convention, Yellow List: list of narcotic drugs under international control, UN convention, United Nations, Vienna, Austria; 2004 [cited 2015 Jun 12]. Available from: http://www.incb.org/documents/Narcotic-Drugs/Yellow_List/NAR_2011_YellowList_50edition_EN.pdf.
   Google Scholar
• Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL. Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend. 2013;129(1-2):116–124.10.1016/j.drugalcdep.2012.09.018
   PubMed Web of Science ®Google Scholar
• Iravani FS, Akhgari M, Jokar F, Bahmanabadi L. Current trends in tramadol-related fatalities, Tehran, Iran 2005-2008. Subst Use Misuse. 2010;45(13):2162–2171.10.3109/10826081003692098
   PubMed Web of Science ®Google Scholar
• List of narcotic drugs under control. Secretary for food and drug affairs, Ministry of Health & Medical Education Iran [Persian language] [cited 2015 Apr 10]. Available from: http://fdo.behdasht.gov.ir/uploads/114_1206_13.pdf.
   Google Scholar
• Awad, N. Now what [Internet]? DEA tosses Tramadol in schedule IV. Published: Jul 10, 2014 [cited 2014 Jul 18]. Available from: http://www.medpagetoday.com/EmergencyMedicine/EmergencyMedicine/46717.
   Google Scholar
• Evans EA, Sullivan MA. Abuse and misuse of antidepressants. Subst Abuse Rehabil. 2014;5:107.
   PubMedGoogle Scholar
• Pedrelli P, Iovieno N, Vitali M, Tedeschini E, Bentley KH, Papakostas GI. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis. J Clin Psychopharmacol. 2011;31(5):582–586.10.1097/JCP.0b013e31822c0adf
   PubMed Web of Science ®Google Scholar
• Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395–400.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Hoon-Kim S, Radhakrishnan R, Williamson EM. A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother Res. 2016;30(5):691–700.10.1002/ptr.v30.5
   PubMed Web of Science ®Google Scholar
• Tovar RT, Petzel RM. Herbal toxicity. Dis Mon. 2009; 55(10):592-641. Review10.1016/j.disamonth.2009.05.001
   PubMed Web of Science ®Google Scholar
• Pringle G, McDonald MP, Gabriel KI. Patterns and perceptions of Dextromethorphan use in adult members of an online Dextromethorphan community. J Psychoactive Drugs. 2015;47(4):267–275.10.1080/02791072.2015.1071448
   PubMed Web of Science ®Google Scholar
• Cole, C, Jones, L, McVeigh, J, Kicman, A, Syed, Q, Bellis, M A. (2010). A guide to adulterants, bulking agents and other contaminants found in illicit drugs (Review) [cited 2016 Mar 3]. Available from: the Liverpool: Centre for public health, Faculty of Health and Applied Social Sciences, Liverpool John Moores University website: www.cph.org.uk/showPublication.aspx?pubid=632.
   Google Scholar
• Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–368.10.1056/NEJMra1604339
   PubMed Web of Science ®Google Scholar
• Pongcharoen P, Fleischer AB. An evidence-based review of systemic treatments for itch. Eur J Pain. 2016;20(1):24–31.10.1002/ejp.766
   PubMed Web of Science ®Google Scholar
• Saran JS, Barbano RL, Schult R, Wiegand TJ, Selioutski O. Chronic diphenhydramine abuse and withdrawal: A diagnostic challenge. Neurol Clin Pract doi: http://dx.doi.org/10.1212/CPJ.0000000000000304.
   Google Scholar
• Hamzaoui S, Moula O, Mustapha MB, Dridi A, Maamri A, Zalila H. Misuse and addiction to Trihexyphenidyl: perception and attitude of Tunisian psychiatrists. Eur Psychiatry. 2015;30:1097.10.1016/S0924-9338(15)30865-8
   Web of Science ®Google Scholar
• WHO fact sheet. Substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products. Updated January 2016. Available from: www.who.int/mediacentre/factsheets/fs275/.
   Google Scholar
• Liang BA. Fade to black: importation and counterfeit drugs. Am J Law Med. 2006;32:279–323.
   PubMed Web of Science ®Google Scholar
• Ambroise-Thomas P. The tragedy caused by fake antimalarial drugs. Mediterr J Hematol Infect Dis. 2012;4(1):e2012027.10.4084/mjhid.2012.027
   PubMedGoogle Scholar
• Jocelyne Sambira. Counterfeit drugs raise Africa’s temperature. Profits too high, penalties too low to stop crime [Internet]. From Africa Renewal: May 2013, page 5 [cited 2016 Jan 5]. Available from: http://www.un.org/africarenewal/magazine/may-2013/counterfeit-drugs-raise-africa%E2%80%99s-temperature#sthash.mU8J46CN.dpuf
   Google Scholar
• Rocha T, Amaral JS, Oliveira MB. Adulteration of dietary supplements by the illegal addition of synthetic drugs: a review. Compr Rev Food Sci Food Saf. 2016;15(1):43–62.10.1111/1541-4337.12173
   PubMed Web of Science ®Google Scholar